The gut-liver axis and the intersection with the microbiome.

Area of Science:

• Gastroenterology and Hepatology
• Microbiome Research
• Translational Medicine

Background:

• Diverse liver diseases share a common spectrum, including nonalcoholic steatohepatitis, alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.
• The gut-liver axis is increasingly recognized for its role in the pathogenesis of alcoholic and nonalcoholic fatty liver disease (NAFLD).
• Advances in high-throughput DNA sequencing and computational biology have enabled deeper interrogation of the microbiome's complexity.

Purpose of the Study:

• To review the intricate communication pathways within the gut-liver axis in the context of liver disease.
• To explore the molecular, genetic, and microbiome-related factors influencing liver health and disease.
• To discuss the potential of the microbiome for diagnosing liver disease progression and predicting treatment responses.

Main Methods:

• Review of current literature on gut-liver axis and microbiome research in liver disease.
• Analysis of molecular, genetic, and microbiome data.
• Exploration of experimental designs combining human studies with mechanistic work in humanized mouse models ('avatar mice').

Main Results:

• The microbiome significantly influences liver disease development and progression.
• Exploiting microbiome-liver axis interactions holds promise for novel therapeutic strategies.
• Humanized 'avatar mice' models are valuable for testing microbiome-based interventions.

Conclusions:

• Understanding the microbiome is key to advancing liver disease diagnosis and treatment.
• Personalized microbiome-informed therapies are a promising future direction.
• Continued research integrating human studies and advanced animal models will accelerate clinical applications.